Learn about nasal polyps a condition that can be mistaken for a common cold and how to identify and treat them effectively ...

Nasal Polyps Can Cause Breathing Difficulties. Nasal polyps can make it hard to breathe out of your nose, forcing you to breathe out of your mouth. Mouth breathing may not seem ...

Medications, such as steroids, certain NSAIDs, and biologics, may help reduce the odds of nasal polyp recurrence. Avoiding triggers, such as cigarette smoke or cold, dry air, can also help keep nasal ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Sanofi and Regeneron's fast-growing immunology drug Dupixent is on course for a third indication in Europe after being recommended for approval as a treatment for people with nasal polyps ...

A team of researchers from China and Hong Kong are betting you would. They’ve developed a swarm of robots that can be ...

Learn how Dupixent helps diverse eczema patients and why inclusive clinical trials are vital for fair healthcare.

Chronic sinusitis usually refers to inflammation in the sinuses ... treatment isn’t working,” says Dr Ponda. Nasal tumours causing blockage and recurring infections: Both benign growths like polyps ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Chronic sinusitis is often a benign condition, but it should not be taken lightly when it becomes persistent or atypical ...

Depemokimab significantly reduces asthma exacerbations, benefiting patients regardless of their baseline asthma control levels. A biologics license application for depemokimab is currently being ...

Etokimab (I-Mab Biopharma), which is optimized for common IL-33 gene polymorphisms, has completed patient recruitment in its ...